Literature DB >> 22472990

Off-label use of drugs and medical devices: a review of policy implications.

R S Stafford1.   

Abstract

Mesh：

Year:  2012        PMID： 22472990     DOI： 10.1038/clpt.2012.22

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.

Authors:  Johann Castañeda-Sanabria; David Hajage; Melisande Le Jouan; Anne Perozziello; Florence Tubach
Journal:  Eur J Clin Pharmacol       Date:  2016-02-26       Impact factor: 2.953

Review 2.  Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.

Authors:  Yuan Luo; William K Thompson; Timothy M Herr; Zexian Zeng; Mark A Berendsen; Siddhartha R Jonnalagadda; Matthew B Carson; Justin Starren
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

Review 3.  Fifty years of preventing and treating childhood behaviour disorders: a systematic review to inform policy and practice.

Authors:  Charlotte Waddell; Christine Schwartz; Caitlyn Andres; Jenny Lou Barican; Donna Yung
Journal:  Evid Based Ment Health       Date:  2018-05

4.  Automated detection of off-label drug use.

Authors:  Kenneth Jung; Paea LePendu; William S Chen; Srinivasan V Iyer; Ben Readhead; Joel T Dudley; Nigam H Shah
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

5.  Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children.

Authors:  Andrew E Mulberg; Timothy Cripps
Journal:  Curr Ther Res Clin Exp       Date:  2019-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.